10th Annual Latest Updates in Multiple Sclerosis and NMOSD: Diagnostic Criteria, Biomarkers and Management

Saturday, March 14, 2026, 8:30 AM - 1:30 PM PT, Hotel Marriot Marina del Rey, Los Angeles, CA


Join us for this continuing medical education (CME) activity focused on the latest advances in multiple sclerosis (MS) and NMOSD. Led by a panel of experts, this program will provide a dynamic and practical overview of the new diagnostic criteria for both MS and NMOSD, emphasizing how recent updates are transforming clinical decision-making. Participants will gain deeper insight into the new biomarkers incorporated into the MS criteria, including the central vein sign (CVS), paramagnetic rim lesions (PRL), and the use of optical coherence tomography (OCT) in diagnosis and prognosis. We will have case-based discussions, and a presentation by a member of the international panel that developed the updated MS diagnostic criteria, offering unique, firsthand perspectives on the rationale and implications of these changes. The program will also explore emerging therapeutic strategies for MS and NMOSD, including novel mechanisms of action and practical management considerations. This evidence-based course will blend expert lectures, panel discussions, and audience interaction to deliver clinically relevant insights that can be immediately applied in practice.

1. Recall the key components of the 2024 McDonald Diagnostic Criteria for multiple sclerosis.
2. Recall the key components of the changes to the NMOSD criteria.
3. Understand the correct use of OCT, Central vein sign and PRL in the diagnosis of multiple sclerosis.
4. Develop appropriate treatment plans using disease modifying therapies for patients with multiple sclerosis.
5. Assess the challenges and best practices in navigating the therapy startup process for MS and NMOSD patients.

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

ANCC Credit for Nurses:  This activity is approved for 4.50 ANCC contact hours.

Interprofessional Continuing Education: This activity was planned by and for the healthcare team and learners will receive 4.50 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

AMA PRA Category 1 Credit(s)™ (MD, DO) (4.50 hours), ANCC (4.50 hours), IPCE (4.50 hours), Non-Physician AMA Attendance (4.50 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, March 14, 2026